World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
63
Citations
23539
World Ranking
9987
National Ranking
764

Overview

Alison H. Banham is affiliated with the University of Oxford in the United Kingdom. Their research primarily focuses on biochemistry, genetics, and molecular biology, with significant work in the fields of medicine, molecular biology, oncology, immunology, and cancer research.

Their studies encompass a range of topics, including:

  • Cell Adhesion Molecules Research
  • Cancer, Hypoxia, and Metabolism
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Angiogenesis and VEGF in Cancer
  • Adenosine and Purinergic Signaling
  • Enzyme function and inhibition

Alison H. Banham has contributed to several notable publications. Recent papers include:

  • "Carbonic anhydrase 9 (CA9) expression in non-small-cell lung cancer: correlation with regulatory FOXP3+T-cell tumour stroma infiltration," 2020, British Journal of Cancer
  • "CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model," 2020, Frontiers in Oncology
  • "Elevated expression of the adhesion GPCR ADGRL4/ELTD1 promotes endothelial sprouting angiogenesis without activating canonical GPCR signalling," 2021, Scientific Reports
  • "High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations," 2020, PLoS ONE
  • "ELTD1 Activation Induces an Endothelial-EMT Transition to a Myofibroblast Phenotype," 2021, International Journal of Molecular Sciences

The frequent co-authors who have collaborated with Banham include:

  • Adrian L. Harris
  • Helen Sheldon
  • Esther Bridges
  • Salwa Lin
  • Demin Li

The main venues where their work has been published are:

  • PLoS ONE
  • British Journal of Cancer
  • Frontiers in Oncology
  • Scientific Reports
  • International Journal of Molecular Sciences

Alison H. Banham's research spans multiple subfields including molecular biology, oncology, immunology, and cancer research, with additional focus on immunology and allergy. Their scientific output integrates studies on cellular mechanisms relevant to cancer progression, immune cell dynamics, and molecular pathways involved in tumor biology and therapy.

Best Publications

  • Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

    Christine P. Hans;Dennis D. Weisenburger;Timothy C. Greiner;Randy D. Gascoyne

  • Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma.

    Charles H. Lawrie;Shira Gal;Heather M. Dunlop;Beena Pushkaran

  • Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

    Gaynor J. Bates;Stephen B. Fox;Cheng Han;Russell D. Leek

  • Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level.

    Giovanna Roncador;Philip J. Brown;Lorena Maestre;Sophie Hue

  • A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy

    William W L Choi;Dennis D. Weisenburger;Timothy Charles Greiner;Miguel A. Piris

  • High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.

    Joaquim Carreras;Armando Lopez-Guillermo;Armando Lopez-Guillermo;Bridget C. Fox;Bridget C. Fox;Lluis Colomo;Lluis Colomo

  • CD4+CD25high T Cells Are Enriched in the Tumor and Peripheral Blood of Prostate Cancer Patients

    Ashley M. Miller;Kajsa Lundberg;Volkan Özenci;Alison H. Banham

  • Expansion of CD4+CD25+and FOXP3+ Regulatory T Cells during the Follicular Phase of the Menstrual Cycle: Implications for Human Reproduction

    Lourdes Arruvito;Marianela Sanz;Alison H. Banham;Leonardo Fainboim

  • Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells.

    Tomás Álvaro;Marylène Lejeune;Ma Teresa Salvadó;Ramón Bosch

  • Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome

    Sharon L. Barrans;James A. L. Fenton;Alison Banham;Roger G. Owen

  • A Core Human Primary Tumor Angiogenesis Signature Identifies the Endothelial Orphan Receptor ELTD1 as a Key Regulator of Angiogenesis

    Massimo Masiero;Filipa Costa Simões;Hee Dong Han;Cameron Snell

  • Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease

    Masayuki Saruta;Qi T. Yu;Phillip R. Fleshner;Pierre Yves Mantel

  • Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.

    Qi T. Yu;Masayuki Saruta;Armine Avanesyan;Phillip R. Fleshner

  • Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients.

    Khoon Lin Ling;Sarah E. Pratap;Gaynor J. Bates;Baljit Singh

  • The notch ligand JAGGED1 as a target for anti-tumor therapy.

    Demin Li;Massimo Masiero;Alison H. Banham;Adrian L. Harris

  • CD molecules 2006 — Human cell differentiation molecules

    Heddy Zola;Bernadette Swart;Alison Banham;Simon Barry

  • Disruption of neural progenitors along the ventricular and subventricular zones in periventricular heterotopia

    Russell J. Ferland;Luis Federico Batiz;Jason Neal;Gewei Lian

  • Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection☆

    Scott M. Ward;Bridget C. Fox;Philip J. Brown;Joy Worthington

  • FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma.

    G Roncador;J F Garcia;L Maestre;E Lucas

  • FOXP3+ regulatory T cells: Current controversies and future perspectives.

    Alison H. Banham;Fiona M. Powrie;Elisabeth Suri-Payer

Frequent Co-Authors

Karen Pulford
Karen Pulford University of Oxford
adrian l harris
adrian l harris University of Oxford
Stephen B. Fox
Stephen B. Fox Peter MacCallum Cancer Centre
David Y. Mason
David Y. Mason John Radcliffe Hospital
Paola Bovolenta
Paola Bovolenta Spanish National Research Council
Bruce E. Torbett
Bruce E. Torbett Seattle Children's Hospital
Elizabeth M. Simpson
Elizabeth M. Simpson University of British Columbia
Wyeth W. Wasserman
Wyeth W. Wasserman University of British Columbia
Reiner A. Veitia
Reiner A. Veitia Université Paris Cité
Peggy J. Farnham
Peggy J. Farnham University of Southern California

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens the door to diverse career pathways, especially in the rapidly growing healthcare sector. One increasingly popular route is medical coding and health information management, both of which can be pursued online for maximum flexibility.

If you’re comparing ccs vs cpc salary prospects, it’s important to know that credentials like Certified Coding Specialist (CCS) and Certified Professional Coder (CPC) each offer distinct salary ranges and career benefits. Both are highly regarded and can be achieved through accredited online programs.

Wondering what is medical coding salary? Medical coders in the U.S. can expect competitive average earnings, especially with growing demand for remote and specialized roles. For many, medical coding answers the question: is medical coding a good career? The job offers stability, flexibility, and a clear career advancement pathway.

To get started, consider enrolling in one of the online health information management degree programs. These offer affordable, flexible options to build new skills and open the door to dynamic health information careers after your Biology or Biochemistry studies.

Best Scientists Citing Alison H. Banham

Trending Scientists